Altair Therapeutics Raises $17 Million
Altair Therapeutics Inc., a San Diego-based drug company focused on respiratory diseases, has raised $17 million in new VC funding. Domain Associates led the round, and was joined by AgeChem Venture Fund and return backers Thomas, McNerney & Partners, Forward Ventures and Isis Pharmaceuticals.
12 November 2009•2 mins read
